Mod GRF, GHRP-6 10mg (Blend)

Mod GRF, GHRP-6 10mg (Blend) — Dual-Action Growth Hormone Secretagogue Research Formulation

This advanced 10mg synergistic formulation combines Mod GRF (1-29) (Modified Growth Hormone-Releasing Factor) with GHRP-6 (Growth Hormone Releasing Peptide-6) to deliver a robust, dual-mechanism architecture for neuroendocrine research. By pairing a stabilized Growth Hormone-Releasing Hormone (GHRH) analogue with a potent Growth Hormone Secretagogue Receptor (GHSR) agonist, this blend allows investigators to explore highly amplified, pulsatile release pathways of endogenous growth hormone.

• Dual-Pathway Signaling Synergy: Simultaneously targets distinct pituitary receptor configurations. Mod GRF (1-29) acts on GHRH receptors, while GHRP-6 binds to the ghrelin/secretagogue receptors to actively suppress somatostatin, resulting in an optimized and highly efficient cellular signaling cascade.

• Key Research Areas: Extensively utilized in metabolic, physiological, and endocrinological studies to investigate lean tissue preservation, visceral adipose tissue reduction, cellular repair mechanisms, and the modulation of appetite signaling pathways.

• Purity Guaranteed: $\ge 99\%$ purity of each constituent peptide within the blend, verified by rigorous HPLC and Mass Spectrometry testing to maintain exact and repeatable experimental baselines.

• Optimal Stability: Supplied as a sterile, lyophilized powder format to protect delicate peptide chains, ensuring excellent structural integrity and straightforward reconstitution for in vitro and laboratory assays.

Note: This product is sold strictly as a high-purity research chemical. It is intended solely for laboratory, in vitro, or animal research applications and is not approved for human injection, therapeutic, or diagnostic use.